Bioequivalence Study of Metformin Hydrochloride 500 mg Film-Coated Tablets in Indonesia Healthy Subject

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 23, 2022

Primary Completion Date

March 24, 2022

Study Completion Date

March 31, 2022

Conditions
Drug Use
Interventions
DRUG

Metformin Hydrochloride 500 MG

Metformin is an antihyperglycemic drug used in the management of type-2 diabetes. Metformin hydrochloride improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.

Trial Locations (1)

10520

PT Pharma Metric Labs, Jakarta Pusat

All Listed Sponsors
collaborator

PT Pharma Metric Labs

INDUSTRY

lead

PT. Pyridam Farma Tbk

INDUSTRY